Jeff Yass’s NanoViricides NNVC Stock Holding History

Jeff Yass’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,500	Closed	-$56.1K	–	13181
2022 Q4	$56.1K	Buy	50,500 +28,000	+124%	+$43.7K	﹤0.01%	11328
2022 Q3	$39K	Buy	+22,500	New	+$49.1K	﹤0.01%	12345
2022 Q1	–	Sell	-19,100	Closed	-$71K	–	13655
2021 Q4	$71K	Sell	19,100 -23,700	-55%	-$108K	﹤0.01%	12366
2021 Q3	$199K	Buy	42,800 +22,300	+109%	+$93K	﹤0.01%	11487
2021 Q2	$95K	Sell	20,500 -60,000	-75%	-$242K	﹤0.01%	12117
2021 Q1	$380K	Buy	+80,500	New	+$364K	﹤0.01%	10097
2020 Q4	–	Sell	-10,400	Closed	-$40K	–	11495
2020 Q3	$40K	Buy	+10,400	New	+$57K	﹤0.01%	10256
2015 Q1	–	Sell	-1,245	Closed	-$68K	–	9755
2014 Q4	$68K	Sell	1,245 -1,390	-53%	-$92K	﹤0.01%	9301
2014 Q3	$158K	Buy	2,635 +245	+10%	+$19.2K	﹤0.01%	8857
2014 Q2	$202K	Sell	2,390 -1,410	-37%	-$100K	﹤0.01%	9049
2014 Q1	$243K	Buy	3,800 +1,620	+74%	+$138K	﹤0.01%	7932
2013 Q4	$209K	Buy	+2,180	New	+$224K	﹤0.01%	8190

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jeff Yass's NNVC Position: Q2 2026 in Review

Jeff Yass reduced its NanoViricides (NNVC) stake by 39% in Q2 2026, selling an estimated $52.7K and leaving 60,616 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12611.

Jeff Yass first reported a position in NNVC in Q1 2014 and has held it in 27 quarters since. The position peaked at $514K in Q1 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Jeff Yass held 60,616 shares of NanoViricides worth $83.7K as of Q2 2026.
Jeff Yass sold 38,415 NanoViricides shares in Q2 2026, an estimated $52.7K.
NanoViricides made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12611 holding.
Jeff Yass first reported a position in NanoViricides in Q1 2014 and has held it in 27 quarters since.
Jeff Yass's NanoViricides position peaked at $514K in Q1 2014.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.